Stock Code
688016.SH
Stock Code
688016.SH
Social Responsibility
Customer Responsibility
Quality System
Our products successfully achieved the TUV certification, UDEM certification, and authentication of the EU registration production system. Meanwhile, met the requirements of medical device production systems in the EU, Brazil, Argentina and other overseas countries.
Customer Requirement
Endovastec™ adheres to customer focus and market-centric, listens to customers and thus wins their satisfaction. Through various market contact opportunities, online or offline communication and related feedback platform, data collection has been constantly strengthened, enabling us to understand the factors that drive customers to purchase and choose, and to cover product evaluation and unmet needs such as price, competition and academics. Therefore, information of products and marketing is collected to further consolidate market share and enable our products to better meet customer’s expectations, diversified needs and enhance brand influence.
Corporate Compliance
Endovastec™ is committed to conducting its business with the highest ethical standards, including compliance with relevant laws, regulations, and industry codes. As part of that commitment, Endovastec™ and its businesses have established effective global compliance programs, which include written policies and procedures, training, and risk control measures. It is our corporate responsibility to promote ethical behavior and build the cornerstone of corporate culture of integrity and compliance. Our Code of Business Conduct and Ethics provides a uniform understanding as to what is expected of all employees and business partners and embodies our commitment to integrity in everything we do.
Environmental Protection and Safety
We attach great importance to environmental and occupational health and safety (EHS), and established EHS management team. In addition, we adopted the certifications of ISO14001 Environmental Management System, ISO45001 EHS Management System, and Secondary Safety Production Standardization. Besides, Safety Management and Implementation System was built based on PDCA cycle method.
Endovastec™ always adheres to the goal of creating a safe, healthy and comfortable working environment for employees, and fully implement the responsibility system in safe production. We insist on “Safety comes first, prevention stays primarily, and management operates comprehensively”, strengthen risk management and process control to ensure a favorable operating condition.
Public Benefit
Relief for Impoverished Patients with Aortic Diseases
Endovastec™ and Shanghai Shangshan Foundation jointly initiated the “Endovastec Public Welfare Action” Special Relief Fund for Impoverished Patients with Aortic Diseases. The fund provides charitable medical assistance for impoverished patients with aortic diseases across China to reduce their financial burden and improve their lives and their family well-being.
Employment and Internships Promotion for College Graduates
Endovastec™ has set up platform for college graduates, which effectively alleviates the employment difficulties, vigorously promotes the cultivation and reserve of talents, and strengthens the strategic cooperation between universities and enterprises.
Implementation of Targeted Poverty Alleviation Project
Endovastec™ is part of the Poverty Alleviation Project to help the poor by investing quinoa plantation.
About us
News
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
©Copyright 1998-2020, Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2020-0065
Website record/ license No.：沪ICP备14048493号-1 
HGWA Bei No.31011502014536
The registered trademarks of “微创", "MicroPort" and"
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
